AU2012226473B8 - Fluoro-pyridinone derivatives useful as antibacterial agents - Google Patents

Fluoro-pyridinone derivatives useful as antibacterial agents Download PDF

Info

Publication number
AU2012226473B8
AU2012226473B8 AU2012226473A AU2012226473A AU2012226473B8 AU 2012226473 B8 AU2012226473 B8 AU 2012226473B8 AU 2012226473 A AU2012226473 A AU 2012226473A AU 2012226473 A AU2012226473 A AU 2012226473A AU 2012226473 B8 AU2012226473 B8 AU 2012226473B8
Authority
AU
Australia
Prior art keywords
fluoro
methyl
methylsulfonyl
butanamide
oxopyridin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2012226473A
Other languages
English (en)
Other versions
AU2012226473A1 (en
AU2012226473B2 (en
Inventor
Matthew Frank Brown
Ye Che
Michael Joseph Melnick
Justin Ian Montgomery
Mark Stephen Plummer
Loren Michael PRICE
Usa Reilly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of AU2012226473A1 publication Critical patent/AU2012226473A1/en
Application granted granted Critical
Publication of AU2012226473B2 publication Critical patent/AU2012226473B2/en
Priority to AU2015215883A priority Critical patent/AU2015215883A1/en
Publication of AU2012226473B8 publication Critical patent/AU2012226473B8/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2012226473A 2011-03-07 2012-02-22 Fluoro-pyridinone derivatives useful as antibacterial agents Active AU2012226473B8 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2015215883A AU2015215883A1 (en) 2011-03-07 2015-08-19 Fluoro-pyridinone derivatives useful as antibacterial agents

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161449825P 2011-03-07 2011-03-07
US61/449,825 2011-03-07
PCT/IB2012/050812 WO2012120397A1 (en) 2011-03-07 2012-02-22 Fluoro-pyridinone derivatives useful as antibacterial agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2015215883A Division AU2015215883A1 (en) 2011-03-07 2015-08-19 Fluoro-pyridinone derivatives useful as antibacterial agents

Publications (3)

Publication Number Publication Date
AU2012226473A1 AU2012226473A1 (en) 2013-09-05
AU2012226473B2 AU2012226473B2 (en) 2015-06-11
AU2012226473B8 true AU2012226473B8 (en) 2015-10-15

Family

ID=45841548

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012226473A Active AU2012226473B8 (en) 2011-03-07 2012-02-22 Fluoro-pyridinone derivatives useful as antibacterial agents

Country Status (34)

Country Link
US (2) US8624034B2 (OSRAM)
EP (1) EP2683689B1 (OSRAM)
JP (1) JP5620020B2 (OSRAM)
KR (1) KR101593288B1 (OSRAM)
CN (2) CN104529883A (OSRAM)
AP (1) AP3336A (OSRAM)
AR (1) AR085615A1 (OSRAM)
AU (1) AU2012226473B8 (OSRAM)
BR (1) BR112013022536B1 (OSRAM)
CA (1) CA2828337C (OSRAM)
CL (1) CL2013002417A1 (OSRAM)
CO (1) CO6761338A2 (OSRAM)
CR (1) CR20130403A (OSRAM)
CU (1) CU20130117A7 (OSRAM)
DO (1) DOP2013000200A (OSRAM)
EA (1) EA024782B1 (OSRAM)
EC (1) ECSP13012928A (OSRAM)
ES (1) ES2626457T3 (OSRAM)
GE (1) GEP20156370B (OSRAM)
GT (1) GT201300213A (OSRAM)
HK (1) HK1209734A1 (OSRAM)
IL (1) IL228100A0 (OSRAM)
MA (1) MA34963B1 (OSRAM)
MX (1) MX341977B (OSRAM)
NI (1) NI201300077A (OSRAM)
PE (1) PE20140397A1 (OSRAM)
PH (1) PH12013501780A1 (OSRAM)
SG (1) SG192766A1 (OSRAM)
TN (1) TN2013000353A1 (OSRAM)
TW (1) TWI453197B (OSRAM)
UA (1) UA107423C2 (OSRAM)
UY (1) UY33936A (OSRAM)
WO (1) WO2012120397A1 (OSRAM)
ZA (1) ZA201306515B (OSRAM)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2735929C (en) 2008-09-19 2013-12-17 Pfizer Inc. Hydroxamic acid derivatives useful as antibacterial agents
EP2512474B1 (en) 2009-12-16 2014-11-05 Pfizer Inc N-linked hydroxamic acid derivatives useful as antibacterial agents
EP2683689B1 (en) 2011-03-07 2017-04-12 Pfizer Inc Fluoro-pyridinone derivatives useful as antibacterial agents
CA2830866A1 (en) * 2011-04-08 2012-10-11 Pfizer Inc. Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
JP2014510132A (ja) 2011-04-08 2014-04-24 ファイザー・インク 抗菌剤として有用なイソオキサゾール誘導体
AR097617A1 (es) 2013-09-13 2016-04-06 Actelion Pharmaceuticals Ltd Derivados antibacterianos del 2h-indazol
WO2015085238A1 (en) * 2013-12-05 2015-06-11 The Regents Of The University Of California, A California Corporation Inhibitors of lpxc
EA030730B1 (ru) * 2013-12-19 2018-09-28 Идорсиа Фармасьютиклз Лтд Антибактериальные производные 1h-индазола и 1h-индола
AR099612A1 (es) 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
WO2015164458A1 (en) 2014-04-22 2015-10-29 Novartis Ag Isoxazoline hydroxamic acid derivatives as lpxc inhibitors
EA201692305A1 (ru) * 2014-05-16 2017-05-31 Актелион Фармасьютиклз Лтд. Антибактериальные хиназолин-4(3н)-оновые производные
HRP20181670T1 (hr) 2014-06-03 2018-12-14 Idorsia Pharmaceuticals Ltd Spojevi pirazola i njihova uporaba kao blokatora kalcijevih kanala t-tipa
BR112017010474A2 (pt) 2014-11-19 2017-12-26 Actelion Pharmaceuticals Ltd derivados antibacterianos de benzotiazol
JP6697466B2 (ja) 2014-12-16 2020-05-20 ノバルティス アーゲー ＬｐｘＣ阻害剤としてのイソオキサゾールヒドロキサム酸化合物
CN104876883B (zh) * 2015-06-05 2017-11-28 安徽联创生物医药股份有限公司 抗失眠药物苏沃雷生中间体的合成方法
AR105646A1 (es) * 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
AR105889A1 (es) 2015-09-03 2017-11-22 Actelion Pharmaceuticals Ltd Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos
HUE050796T2 (hu) 2016-06-14 2021-01-28 Novartis Ag (R)-4-(5-(ciklopropiletinil)izoxazol-3-il)-N-hidroxi-2-metil-2-(metilszulfonil)butánamid kristályos formája baktériumellenes szerként
EP3554490B1 (en) 2016-12-16 2022-02-16 Idorsia Pharmaceuticals Ltd Pharmaceutical combination comprising a t-type calcium channel blocker
TWI808960B (zh) 2017-02-06 2023-07-21 瑞士商愛杜西亞製藥有限公司 用於合成1-芳基-1-三氟甲基環丙烷之新穎方法
US11981696B2 (en) 2018-03-15 2024-05-14 Pfizer Inc. Fluoro-pyridinone phosphates and boronates useful as antibacterial agents
RU2754177C1 (ru) * 2018-03-15 2021-08-30 Пфайзер Инк. Пиридинон- и пиримидинон-фосфаты и боронаты, полезные в качестве антибактериальных агентов
CN110699312B (zh) * 2019-11-28 2022-08-12 西北农林科技大学 一种猪种布鲁氏菌bi-1基因缺失菌株及其构建方法和应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769461A (en) 1986-09-16 1988-09-06 American Home Products Corporation Quinolinyl benzene hydroxamic acids as anti-inflammatory/antiallergic agents
US5110831A (en) 1990-11-30 1992-05-05 Du Pont Merck Pharmaceutical Company Vinylogous hydroxamic acids and derivatives thereof as 5-lipoxygenase inhibitors
NZ505675A (en) 1998-02-07 2002-11-26 British Biotech Pharm N-alkylamide substituted hydroxamic acid derivatives are used as antibacterial agents
GB9925470D0 (en) 1999-10-27 1999-12-29 Smithkline Beecham Plc Novel compounds
US20050119305A1 (en) 2001-03-21 2005-06-02 Masao Naka Il-6 production inhibitors
ES2180456B1 (es) 2001-07-20 2004-05-01 Laboratorios S.A.L.V.A.T., S.A. Isoxazoles sustituidos y su utilizacion como antibioticos.
DE60330126D1 (de) * 2002-02-14 2009-12-31 Pharmacia Corp Substituierte pyridinone als modulatoren für p38 map kinase
CA2512582C (en) 2003-01-08 2014-07-08 University Of Washington Antibacterial agents
GB0302431D0 (en) 2003-01-30 2003-03-05 Glaxo Group Ltd Novel compounds
MX2007006961A (es) 2004-12-10 2007-10-04 Univ Emory Analogos nucleosidos de ciclobutilo 2' y 3'-sustituidos para el tratamiento de infeccciones virales y proliferacion celular anormal.
WO2006118155A1 (ja) 2005-04-27 2006-11-09 Ishihara Sangyo Kaisha, Ltd. ビフェニル誘導体又はその塩、並びにそれらを有効成分として含有する農園芸用殺菌剤
WO2006124897A2 (en) 2005-05-13 2006-11-23 Lexicon Genetics Incorporated Methods and compositions for improving cognition
JP2009520695A (ja) * 2005-12-15 2009-05-28 ヴィキュロン ファーマシューティカルズ インコーポレイテッド 抗菌活性を有するｎ−ヒドロキシアミド誘導体
US20080085893A1 (en) 2006-10-06 2008-04-10 Shyh-Ming Yang Matrix metalloprotease inhibitors
US7879911B2 (en) 2007-02-01 2011-02-01 Johnson Alan T Hydroxamic acid derivatives of phenoxy-acetic acids and analogs useful as therapeutic agents for treating anthrax poisoning
WO2008105515A1 (ja) 2007-02-28 2008-09-04 Taisho Pharmaceutical Co., Ltd. 新規なヒドロキサム酸誘導体
US20080234297A1 (en) 2007-03-20 2008-09-25 Changgeng Qian HSP90 Inhibitors Containing a Zinc Binding Moiety
CN101239978A (zh) * 2008-03-05 2008-08-13 南方医科大学 一种咪唑并吡啶类化合物
US20110212080A1 (en) * 2008-08-04 2011-09-01 Umar Faruk Mansoor Urea derivatives as antibacterial agents
JP5455913B2 (ja) 2008-08-27 2014-03-26 大正製薬株式会社 ナフチリジン−ｎ−オキシドを有する新規ヒドロキサム酸誘導体
US8372885B2 (en) 2008-09-17 2013-02-12 Novartis Ag Organic compounds and their uses
CA2735929C (en) 2008-09-19 2013-12-17 Pfizer Inc. Hydroxamic acid derivatives useful as antibacterial agents
WO2010100475A1 (en) 2009-03-02 2010-09-10 Astrazeneca Ab Hydroxamic acid derivatives as gram-negative antibacterial agents
US20120238546A1 (en) * 2009-06-16 2012-09-20 Zhaoning Zhu Gamma secretase modulators
US20120245158A1 (en) * 2009-06-16 2012-09-27 Xianhai Huang Gamma secretase modulators
EP2512474B1 (en) * 2009-12-16 2014-11-05 Pfizer Inc N-linked hydroxamic acid derivatives useful as antibacterial agents
EP2683689B1 (en) 2011-03-07 2017-04-12 Pfizer Inc Fluoro-pyridinone derivatives useful as antibacterial agents
CA2830866A1 (en) 2011-04-08 2012-10-11 Pfizer Inc. Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
JP2014510132A (ja) 2011-04-08 2014-04-24 ファイザー・インク 抗菌剤として有用なイソオキサゾール誘導体

Also Published As

Publication number Publication date
UY33936A (es) 2012-10-31
CN103443079A (zh) 2013-12-11
CA2828337A1 (en) 2012-09-13
PH12013501780A1 (en) 2019-07-03
AR085615A1 (es) 2013-10-16
US20120232083A1 (en) 2012-09-13
EA024782B1 (ru) 2016-10-31
CU20130117A7 (es) 2013-10-29
WO2012120397A1 (en) 2012-09-13
BR112013022536A2 (pt) 2016-11-29
KR101593288B1 (ko) 2016-02-11
DOP2013000200A (es) 2014-06-15
AP2013007074A0 (en) 2013-08-31
US20140057919A1 (en) 2014-02-27
HK1191951A1 (en) 2014-08-08
HK1209734A1 (en) 2016-04-08
CN104529883A (zh) 2015-04-22
US8624034B2 (en) 2014-01-07
US8779148B2 (en) 2014-07-15
CR20130403A (es) 2013-09-18
BR112013022536B1 (pt) 2020-05-26
CL2013002417A1 (es) 2013-12-13
TN2013000353A1 (fr) 2015-01-20
MX2013010276A (es) 2013-10-01
MX341977B (es) 2016-09-07
CN103443079B (zh) 2015-06-03
UA107423C2 (en) 2014-12-25
EA201391072A1 (ru) 2014-02-28
GEP20156370B (en) 2015-09-25
JP2014507464A (ja) 2014-03-27
CO6761338A2 (es) 2013-09-30
KR20130131459A (ko) 2013-12-03
AP3336A (en) 2015-07-31
CA2828337C (en) 2016-05-03
NZ614205A (en) 2014-06-27
MA34963B1 (fr) 2014-03-01
TW201249798A (en) 2012-12-16
ECSP13012928A (es) 2013-11-29
EP2683689B1 (en) 2017-04-12
ES2626457T3 (es) 2017-07-25
AU2012226473A1 (en) 2013-09-05
JP5620020B2 (ja) 2014-11-05
AU2012226473B2 (en) 2015-06-11
NI201300077A (es) 2014-01-07
IL228100A0 (en) 2013-09-30
SG192766A1 (en) 2013-09-30
TWI453197B (zh) 2014-09-21
ZA201306515B (en) 2014-05-28
EP2683689A1 (en) 2014-01-15
PE20140397A1 (es) 2014-03-28
GT201300213A (es) 2014-06-06

Similar Documents

Publication Publication Date Title
AU2012226473B8 (en) Fluoro-pyridinone derivatives useful as antibacterial agents
DK2512474T3 (en) N-linked hydroxamic acid derivatives which can be used as antibacterial agents
AU2015215883A1 (en) Fluoro-pyridinone derivatives useful as antibacterial agents
OA16551A (en) Fluoro-pyridinone derivatives useful as antibacterial agents.
NZ614205B2 (en) Fluoro-pyridinone derivatives useful as antibacterial agents
HK1191951B (en) Fluoro-pyridinone derivatives useful as antibacterial agents

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
TH Corrigenda

Free format text: IN VOL 29 , NO 22 , PAGE(S) 3373 UNDER THE HEADING APPLICATIONS ACCEPTED - NAME INDEX UNDER THE NAME PFIZER INC., APPLICATION NO. 2012226473, UNDER INID (72) CORRECT THE CO-INVENTOR TO BROWN, MATTHEW FRANK